The Venture Codex Logo

The Venture Codex

Parkinson's UK

50 Broadway, London, SW1H 0DB, United Kingdom

Overview

Support and research charity for Parkinson's disease.

Founded

1969

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Grant
Seed

Geographic focus

Finland
United Kingdom
United States

Sector focus

Association
Non Profit

Investment portfolio

5rounds
NAMEDATESIZE
Herantis Pharma
Jul 2024Led
$4 MOther Equity
MISSION Therapeutics
Jul 2024Led
$5 MGrant
Lucy Therapeutics
May 2024Participated
$13 MOther Equity
NRG Therapeutics
Aug 2021Led
$0.67 MOther Equity
NRG Therapeutics
Jul 2019Led
$1 MSeed
Herantis Pharma
Jul 2024Led
$4 MOther Equity
MISSION Therapeutics
Jul 2024Led
$5 MGrant
Lucy Therapeutics
May 2024Participated
$13 MOther Equity
NRG Therapeutics
Aug 2021Led
$0.67 MOther Equity
NRG Therapeutics
Jul 2019Led
$1 MSeed
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Parkinson's UK: 5 funding rounds are recorded in the selected participation categories.All available history.
Parkinson's UK: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Other Equity21
Grant10

Monthly Deal Activity

Parkinson's UK: 5 deals are recorded across 88 months.All available history.
Parkinson's UK: 5 deals are recorded across 88 months. All available history
MonthDeals
Jul '191
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '211
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '242
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Parkinson's UK: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Parkinson's UK: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5
Space & Frontier Tech2

Deal Size Distribution

Parkinson's UK: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Parkinson's UK: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M1
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Parkinson's UK: Europe has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Parkinson's UK: Europe has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
Europe4
United States1
Parkinson's UK: 3 co-investors are shown, with The Michael J. Fox Foundation for Parkinson's Research sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Parkinson's UK: 3 co-investors are shown, with The Michael J. Fox Foundation for Parkinson's Research sharing 3 recorded deals. All available history
Co-investorShared deals
The Michael J. Fox Foundation for Parkinson's Research3
Engine Ventures1
Safar Partners1

Investment Strategy

Parkinson's UK: Led accounts for 80% and participating for 20% of round participation.All available history.
Parkinson's UK: Led accounts for 80% and participating for 20% of round participation. All available history
CategoryDeals (count)Share (%)
Led480%
Participating120%
Parkinson's UK: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Parkinson's UK: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead250%
Co-led250%

Team

Arthur Roach

Director of Research

Caroline Rassell

Chief Executive Officer

Julie Dodd

Director of Digital Transformation and Communication